Erin D Michos1, Jeffrey R Misialek2, Elizabeth Selvin3, Aaron R Folsom2, James S Pankow2, Wendy S Post4, Pamela L Lutsey2. 1. Division of Cardiology, Johns Hopkins University School of Medicine, United States; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, United States. Electronic address: edonnell@jhmi.edu. 2. Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, United States. 3. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, United States. 4. Division of Cardiology, Johns Hopkins University School of Medicine, United States; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, United States.
Abstract
BACKGROUND: In observational studies, low 25-hydroxyvitamin D (25(OH)D) has been associated with increased risk of coronary heart disease (CHD), and this association may vary by race. Racial differences in the frequency of vitamin D binding protein (DBP) single nucleotide polymorphisms (SNPs) might account for similar bioavailable vitamin D in blacks despite lower mean 25(OH)D. We hypothesized that the associations of low 25(OH)D with CHD risk would be stronger among whites and among persons with genotypes associated with higher DBP levels. METHODS: We measured 25(OH)D by mass spectroscopy in 11,945 participants in the ARIC Study (baseline 1990-1992, mean age 57 years, 59% women, 24% black). Two DBP SNPs (rs7041; rs4588) were genotyped. We used adjusted Cox proportional hazards models to examine the association of 25(OH)D with adjudicated CHD events through December 2011. RESULTS: Over a median of 20 years, there were 1230 incident CHD events. Whites in the lowest quintile of 25(OH)D (<17 ng/ml) compared to the upper 4 quintiles had an increased risk of incident CHD (HR 1.28, 95% CI 1.05-1.56), but blacks did not (1.03, 0.82-1.28), after adjustment for demographics and behavioral/socioeconomic factors (p-interaction with race = 0.22). Results among whites were no longer significant after further adjustment for potential mediators of this association (i.e. diabetes, hypertension). There was no statistically significant interaction of 25(OH)D with the DBP SNPs rs4588 (p = 0.92) or rs7041 (p = 0.87) in relation to CHD risk. CONCLUSIONS: Low 25(OH)D was associated with incident CHD in whites, but no interactions of 25(OH)D with key DBP genotypes was found.
BACKGROUND: In observational studies, low 25-hydroxyvitamin D (25(OH)D) has been associated with increased risk of coronary heart disease (CHD), and this association may vary by race. Racial differences in the frequency of vitamin D binding protein (DBP) single nucleotide polymorphisms (SNPs) might account for similar bioavailable vitamin D in blacks despite lower mean 25(OH)D. We hypothesized that the associations of low 25(OH)D with CHD risk would be stronger among whites and among persons with genotypes associated with higher DBP levels. METHODS: We measured 25(OH)D by mass spectroscopy in 11,945 participants in the ARIC Study (baseline 1990-1992, mean age 57 years, 59% women, 24% black). Two DBP SNPs (rs7041; rs4588) were genotyped. We used adjusted Cox proportional hazards models to examine the association of 25(OH)D with adjudicated CHD events through December 2011. RESULTS: Over a median of 20 years, there were 1230 incident CHD events. Whites in the lowest quintile of 25(OH)D (<17 ng/ml) compared to the upper 4 quintiles had an increased risk of incident CHD (HR 1.28, 95% CI 1.05-1.56), but blacks did not (1.03, 0.82-1.28), after adjustment for demographics and behavioral/socioeconomic factors (p-interaction with race = 0.22). Results among whites were no longer significant after further adjustment for potential mediators of this association (i.e. diabetes, hypertension). There was no statistically significant interaction of 25(OH)D with the DBP SNPs rs4588 (p = 0.92) or rs7041 (p = 0.87) in relation to CHD risk. CONCLUSIONS: Low 25(OH)D was associated with incident CHD in whites, but no interactions of 25(OH)D with key DBP genotypes was found.
Authors: Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; Michael J Blaha; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Rachel H Mackey; David J Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Robert W Neumar; Graham Nichol; Dilip K Pandey; Nina P Paynter; Matthew J Reeves; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner Journal: Circulation Date: 2013-12-18 Impact factor: 29.690
Authors: A D White; A R Folsom; L E Chambless; A R Sharret; K Yang; D Conwill; M Higgins; O D Williams; H A Tyroler Journal: J Clin Epidemiol Date: 1996-02 Impact factor: 6.437
Authors: Pamela L Lutsey; Erin D Michos; Jeffrey R Misialek; James S Pankow; Laura Loehr; Elizabeth Selvin; Jared P Reis; Myron Gross; John H Eckfeldt; Aaron R Folsom Journal: JACC Heart Fail Date: 2015-04-08 Impact factor: 12.035
Authors: Stefanie S Schleithoff; Armin Zittermann; Gero Tenderich; Heiner K Berthold; Peter Stehle; Reiner Koerfer Journal: Am J Clin Nutr Date: 2006-04 Impact factor: 7.045
Authors: Thomas J Wang; Michael J Pencina; Sarah L Booth; Paul F Jacques; Erik Ingelsson; Katherine Lanier; Emelia J Benjamin; Ralph B D'Agostino; Myles Wolf; Ramachandran S Vasan Journal: Circulation Date: 2008-01-07 Impact factor: 29.690
Authors: Rona J Strawbridge; Anna Deleskog; Olga McLeod; Lasse Folkersen; Maryam Kavousi; Karl Gertow; Damiano Baldassarre; Fabrizio Veglia; Karin Leander; Bruna Gigante; Jussi Kauhanen; Rainer Rauramaa; Andries J Smit; Elmo Mannarino; Philippe Giral; Abbas Dehghan; Albert Hofman; Oscar H Franco; Steve E Humphries; Elena Tremoli; Ulf de Faire; Sven Gustafsson; Claes-Göran Östensson; Per Eriksson; John Öhrvik; Anders Hamsten Journal: Diabetologia Date: 2014-03-25 Impact factor: 10.122
Authors: Di Zhao; Pamela Ouyang; Ian H de Boer; Pamela L Lutsey; Youssef M K Farag; Eliseo Guallar; David S Siscovick; Wendy S Post; Rita R Kalyani; Kevin L Billups; Erin D Michos Journal: Maturitas Date: 2016-11-29 Impact factor: 4.342
Authors: Cassianne Robinson-Cohen; Leila R Zelnick; Andrew N Hoofnagle; Pamela L Lutsey; Gregory Burke; Erin D Michos; Steven J C Shea; Russell Tracy; David S Siscovick; Bruce Psaty; Bryan Kestenbaum; Ian H de Boer Journal: J Clin Endocrinol Metab Date: 2017-08-01 Impact factor: 5.958
Authors: Ian R Rapson; Erin D Michos; Alvaro Alonso; Alan T Hirsch; Kunihiro Matsushita; Jared P Reis; Pamela L Lutsey Journal: Atherosclerosis Date: 2017-01-16 Impact factor: 5.162
Authors: Kathleen Chin; Di Zhao; Martin Tibuakuu; Seth S Martin; Chiadi E Ndumele; Roberta Florido; B Gwen Windham; Eliseo Guallar; Pamela L Lutsey; Erin D Michos Journal: J Clin Endocrinol Metab Date: 2017-04-01 Impact factor: 5.958
Authors: Youssef M K Farag; Eliseo Guallar; Di Zhao; Rita R Kalyani; Michael J Blaha; David I Feldman; Seth S Martin; Pamela L Lutsey; Kevin L Billups; Erin D Michos Journal: Atherosclerosis Date: 2016-07-29 Impact factor: 5.162
Authors: Devika Chawla; Bernard Fuemmeler; Sara E Benjamin-Neelon; Cathrine Hoyo; Susan Murphy; Julie L Daniels Journal: J Matern Fetal Neonatal Med Date: 2017-12-04
Authors: Julia B Ward; Danielle R Gartner; Katherine M Keyes; Mike D Fliss; Elizabeth S McClure; Whitney R Robinson Journal: Ann Epidemiol Date: 2018-09-29 Impact factor: 3.797